Timothy Heaphy

Abbott Labs wrongly pushed Depakote for dementia care, will pay $1.5 billion

Abbott Labs wrongly pushed Depakote for dementia care, will pay $1.5 billion

By

Abbott Laboratories has pleaded guilty and agreed to pay $1.5 billion over allegations that it promoted the anti-seizure drug Depakote for uses that were not approved by the Food and Drug Administration.